Default company panoramic image


INanoBio is developing advanced nano sensor technologies for genome sequencing and personalized healthcare of the future.

  • Stage Prototype Ready
  • Industry Nanotechnology
  • Location Phoenix, Arizona, US
  • Currency USD
  • Founded March 2007
  • Employees 8
  • Website

Company Summary

We are developing a fourth generation nanopore sensor for ultra-fast genome sequencing, funded by NIH under the $1000 genome program. Our aim is to produce a sequencer capable of sequencing the whole genome in 15 minutes, costing only $100. Our first-to-market product is a cancer drug discovery and diagnostics platform. We are raising Series-A financing to develop the genome sequencer prototype and cancer drug discovery and diagnostics system.